Filing Flows › Ironwood Pharmaceuticals (IRWD) › How it makes money
How Ironwood Pharmaceuticals (IRWD) makes money
Ironwood Pharmaceuticals (IRWD) made $133M of revenue in the third quarter 2026 (Q3 2026), +9% from a year earlier. Of every dollar of revenue, 70¢ was left as operating profit, 45¢ was left as net earnings.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $133M | 100.0% |
| Operating profit | $93.1M | 70.0% |
| Income tax | $27.8M | 20.9% |
| Net earnings | $59.8M | 45.0% |
| Operating cash flow | $67.4M | 50.7% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $133M | +9% |
| Q2 2026 | $113M | +33% |
| Q1 2026 | $107M | +159% |
| Q4 2025 | $47.7M | -47% |
| Q3 2025 | $122M | +33% |
| Q2 2025 | $85.2M | -10% |
| Q1 2025 | $41.1M | -45% |
From Ironwood Pharmaceuticals' 10-Q filed Nov 5, 2026 (on EDGAR).
Questions
How does Ironwood Pharmaceuticals make money?
Ironwood Pharmaceuticals (IRWD) made $133M of revenue in the third quarter 2026 (Q3 2026), +9% from a year earlier. Of every dollar of revenue, 70¢ was left as operating profit, 45¢ was left as net earnings.
What is Ironwood Pharmaceuticals' profit margin?
Net earnings were $59.8M, 45.0% of revenue, in the third quarter 2026; the operating margin was 70.0%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.